MedTrace Logo

Reducing Total Cardiovascular Risk in an Urban Community

NCT00241904 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 525

Last updated 2017-09-15

Study results available
· View outcomes & findings →

Summary

PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER.

The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.

Conditions

Interventions

BEHAVIORAL

Lifestyle Changes

Nutrition counseling, smoking cessation counseling, medication compliance counseling, exercise

DRUG

Antiplatelet Agents

Aspirin 81 mg q day

DRUG

Beta Blocker

Oral medication

DRUG

ACE Inhibitors

Oral medications, received 1-2 times per day

Sponsors & Collaborators

Principal Investigators

  • Jerilyn Allen · Johns Hopkins University School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2010-05-31
Completion
2010-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241904 on ClinicalTrials.gov